Holen Sie sich die Stockscreener-App
1.82
2.25%
0.04
Schlusskurs vom Vortag:
$1.78
Offen:
$1.71
24-Stunden-Volumen:
99,657
Relative Volume:
1.35
Marktkapitalisierung:
$84.64M
Einnahmen:
$63.69M
Nettoeinkommen (Verlust:
$-44.82M
KGV:
-0.91
EPS:
-2
Netto-Cashflow:
$-30.56M
1W Leistung:
+0.55%
1M Leistung:
+13.75%
6M Leistung:
+10.98%
1J Leistung:
-35.35%
1-Tages-Spanne:
$1.70
$1.83
1-Wochen-Bereich:
$1.70
$1.99
52-Wochen-Spanne:
$1.35
$3.50
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MDXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
1.805 | 84.64M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
404.32 | 153.96B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.40 | 138.19B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
511.40 | 39.13B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.64 | 30.65B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
139.73 | 26.52B | 15.50B | 1.33B | 2.16B | 7.34 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... - Yahoo
MDxHealth Reports Strong Q1 2025 Revenue Growth - TipRanks
MDxHealth ADR earnings missed by $0.01, revenue topped estimates - Investing.com
MDxHealth SA reports results for the quarter ended March 31Earnings Summary - TradingView
MDxHealth Reports Q1 2025 Financial Results with Increased Revenue but Continued Losses - TipRanks
MDxHealth Reports Q1-2025 Results - The Manila Times
MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead o - GuruFocus
MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance
MDXHEALTH SA Earnings Preview: Recent $MDXH Insider Trading, Hedge Fund Activity, and More - Nasdaq
MDxHealth (MDXH) Projected to Post Quarterly Earnings on Wednesday - Defense World
MDxHealth Reports Strong Financial Turnaround in 2024 - TipRanks
Renaissance Technologies LLC Boosts Stake in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth Schedules Key Shareholders’ Meetings for May 2025 - TipRanks
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight - GlobeNewswire Inc.
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 - The Manila Times
Mdxhealth to Release First Quarter 2025 Financial Results on May 14 | Nation/World | bdtonline.com - Bluefield Daily Telegraph
MDxHealth SA Announces Promising Research Results with New Liquid Biopsy Test in Development - marketscreener.com
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Bleichroeder LP's Strategic Acquisition of MDxHealth SA Shares - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Short Interest Up 133.8% in February - Defense World
Oppenheimer & Co. Inc. Has $47,000 Holdings in MDxHealth SA (NASDAQ:MDXH) - Defense World
MDxHealth CEO acquires company shares worth $80,000 By Investing.com - Investing.com Australia
MDxHealth stock hits 52-week low at $1.49 amid market challenges - Investing.com Canada
MDxHealth stock hits 52-week low at $1.49 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth CEO acquires company shares worth $80,000 - Investing.com India
Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH) - Yahoo Finance
Research Analysts Issue Forecasts for MDxHealth Q1 Earnings - Defense World
What is William Blair’s Forecast for MDxHealth Q1 Earnings? - Defense World
MDxHealth SA (MDXH) Reports Q4 Loss, Tops Revenue Estimates - MSN
MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN
Mdxhealth S.A. Reports Strong Revenue Growth in Earnings Call - TipRanks
MDxHealth (NASDAQ:MDXH) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Q4 2024 Earnings Call Transcript - Insider Monkey
Mdxhealth fourth quarter revenue grows 28% to USD 24.7M - Medical Buyer
MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Yahoo Finance
MDxHealth ADR earnings beat by $0.05, revenue topped estimates - Investing.com South Africa
MDxHealth SA reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: MDxHealth beats Q4 2024 EPS forecast, stock rises - Investing.com
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results - The Manila Times
Earnings Flash (MDXH) MDxHealth SA Reports Q4 Revenue $24.7M, vs. FactSet Est of $23.3M - Marketscreener.com
Can MDxHealth's 28% Revenue Growth Finally Deliver Profitability in 2025? - StockTitan
MDxHealth SA expected to post a loss of 19 cents a shareEarnings Preview - TradingView
MDxHealth (MDXH) Projected to Post Earnings on Wednesday - Defense World
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26 - The Manila Times
MDxHealth Earnings Alert: Key Financial Results & Strategic Updates Unveiled Next Week - Stock Titan
MDxHealth's study on assureMDx published in Journal of Urology - Reuters.com
MDxHealth SA Provides Revenue Guidance for the Fourth Quarter of 2024, Full Year of 2024 and Year 2025 - Marketscreener.com
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance - The Manila Times
MDxHealth Reports Strong 28% Revenue Growth, Projects EBITDA Profitability in 2025 - StockTitan
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.53%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):